Active — Not RecruitingNot Applicable

Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western Pennsylvania

United States1,647 participantsStarted 2019-10-23

Plain-language summary

This is a prospective clinical trial that will examine if contrast-enhanced mammography substantially improves breast cancer detection compared to mammography with tomosynthesis, with minimal increase in false-positives, in women with a personal history of breast cancer.

Who can participate

Age range30 Years – 85 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓Asymptomatic women, ages 30-85, with a personal history of breast cancer who have had at least one routine mammogram since treatment.

What they're measuring

Cancer Detection

Timeframe: 48 months

Trial details

NCT IDNCT04085510

SponsorWendie Berg

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-09-10

View on ClinicalTrials.gov More Breast Cancer Female trials